Oncologists Lobby Senate To Tweak Drug Pricing Bill To Pay Docs More

By John Wilkerson / November 24, 2021 at 10:34 AM
Cancer doctors are lobbying for changes to House-passed drug pricing legislation after an Avalere Health study found the bill would cut an average 40% off the Medicare add-on payment to doctors for administering drugs that are subject to negotiation. The Community Oncology Alliance wants the Senate to continue Medicare’s current policy of paying doctors a drug’s average sales price in the commercial market plus 6%, as opposed to the House bill’s new policy of paying doctors 106% of a drug’s...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.